Cargando…
Sox2 promotes tamoxifen resistance in breast cancer cells
Development of resistance to therapy continues to be a serious clinical problem in breast cancer management. Cancer stem/progenitor cells have been shown to play roles in resistance to chemo- and radiotherapy. Here, we examined their role in the development of resistance to the oestrogen receptor an...
Autores principales: | Piva, Marco, Domenici, Giacomo, Iriondo, Oihana, Rábano, Miriam, Simões, Bruno M, Comaills, Valentine, Barredo, Inmaculada, López-Ruiz, Jose A, Zabalza, Ignacio, Kypta, Robert, Vivanco, Maria d M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936493/ https://www.ncbi.nlm.nih.gov/pubmed/24178749 http://dx.doi.org/10.1002/emmm.201303411 |
Ejemplares similares
-
A Sox2–Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells
por: Domenici, Giacomo, et al.
Publicado: (2019) -
Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions
por: Iriondo, Oihana, et al.
Publicado: (2015) -
Protective effect of stromal Dickkopf-3 in prostate cancer: opposing roles for TGFBI and ECM-1
por: Al Shareef, Zainab, et al.
Publicado: (2018) -
In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer
por: Mazo, Claudia, et al.
Publicado: (2018) -
Intravital imaging of Wnt/β-catenin and ATF2-dependent signalling pathways during tumour cell invasion and metastasis
por: Stoletov, Konstantin, et al.
Publicado: (2023)